144 related articles for article (PubMed ID: 28628920)
1. Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
Jia QW; Chen ZH; Ding XQ; Liu JY; Ge PC; An FH; Li LH; Wang LS; Ma WZ; Yang ZJ; Jia EZ
Cell Physiol Biochem; 2017; 42(2):808-823. PubMed ID: 28628920
[TBL] [Abstract][Full Text] [Related]
2. Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease.
Ding XQ; Ge PC; Liu Z; Jia H; Chen X; An FH; Li LH; Chen ZH; Mao HW; Li ZY; Gu Y; Zhu TB; Li CJ; Wang LS; Ma WZ; Yang ZJ; Jia EZ
Sci Rep; 2015 Oct; 5():14925. PubMed ID: 26446730
[TBL] [Abstract][Full Text] [Related]
3. Circulating MiR-146a May be a Potential Biomarker of Coronary Heart Disease in Patients with Subclinical Hypothyroidism.
Quan X; Ji Y; Zhang C; Guo X; Zhang Y; Jia S; Ma W; Fan Y; Wang C
Cell Physiol Biochem; 2018; 45(1):226-236. PubMed ID: 29357324
[TBL] [Abstract][Full Text] [Related]
4. Association between circulating microRNA-208a and severity of coronary heart disease.
Zhang Y; Li HH; Yang R; Yang BJ; Gao ZY
Scand J Clin Lab Invest; 2017 Sep; 77(5):379-384. PubMed ID: 28554251
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-126 and miR-130a levels correlate with lower disease risk, disease severity, and reduced inflammatory cytokine levels in acute ischemic stroke patients.
Jin F; Xing J
Neurol Sci; 2018 Oct; 39(10):1757-1765. PubMed ID: 30030634
[TBL] [Abstract][Full Text] [Related]
6. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
[TBL] [Abstract][Full Text] [Related]
7. Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease.
de Gonzalo-Calvo D; Cenarro A; Garlaschelli K; Pellegatta F; Vilades D; Nasarre L; Camino-Lopez S; Crespo J; Carreras F; Leta R; Catapano AL; Norata GD; Civeira F; Llorente-Cortes V
J Mol Cell Cardiol; 2017 May; 106():55-67. PubMed ID: 28342976
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on the association of single nucleotide polymorphism in the promoter region of pre-miR-320b-2 with coronary heart disease risk and factors influencing circulating microRNA-320b level].
Feng J; Huang S; He M; Dai X; Li J; Deng Q; Qiu G; Yang B; Wu T
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Oct; 48(10):893-9. PubMed ID: 25573129
[TBL] [Abstract][Full Text] [Related]
9. Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity.
Jin F; Xing J
Neurol Sci; 2017 Nov; 38(11):2015-2023. PubMed ID: 28875333
[TBL] [Abstract][Full Text] [Related]
10. Alteration in microRNA-155 level correspond to severity of coronary heart disease.
Qiu XK; Ma J
Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-33b levels are associated with the presence and severity of coronary heart disease.
Chen C; Liu Q; Li Y; Yu JW; Wang SD; Xu JL; Liu L
Scand J Clin Lab Invest; 2024 Apr; 84(2):133-137. PubMed ID: 38597780
[TBL] [Abstract][Full Text] [Related]
12. Circulating pro-angiogenic micro-ribonucleic acid in patients with coronary heart disease.
Zhang H; Hao J; Sun X; Zhang Y; Wei Q
Interact Cardiovasc Thorac Surg; 2018 Sep; 27(3):336-342. PubMed ID: 29608698
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA profiles based on direct S-Poly(T)Plus assay for detection of coronary heart disease.
Su M; Niu Y; Dang Q; Qu J; Zhu D; Tang Z; Gou D
J Cell Mol Med; 2020 Jun; 24(11):5984-5997. PubMed ID: 32343493
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a in coronary heart disease: Correlation with disease risk, blood lipid, stenosis degree, inflammatory cytokines, and cell adhesion molecules.
Li H; Chen M; Feng Q; Zhu L; Bai Z; Wang B; Guo Z; Hou A; Li H
J Clin Lab Anal; 2022 Jan; 36(1):e24138. PubMed ID: 34861059
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1/VN interactions.
Luo M; Wang G; Xu C; Zeng M; Lin F; Wu J; Wan Q
Life Sci; 2019 Dec; 239():117092. PubMed ID: 31760103
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Circulating miR-765, miR-93-5p, and miR-433-3p to Obstructive Coronary Heart Disease Evaluated by Cardiac Computed Tomography.
Infante T; Forte E; Punzo B; Cademartiri F; Cavaliere C; Soricelli A; Salvatore M; Napoli C
Am J Cardiol; 2019 Jul; 124(2):176-182. PubMed ID: 31084998
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1, miR-26a, and miR-195 in coronary heart disease patients: Correlation with stenosis degree, cholesterol levels, inflammatory cytokines, and cell adhesion molecules.
Li J; Chen Z; Wang X; Song H
J Clin Lab Anal; 2022 Jan; 36(1):e24070. PubMed ID: 34850451
[TBL] [Abstract][Full Text] [Related]
18. Relation of circulating lncRNA GAS5 and miR-21 with biochemical indexes, stenosis severity, and inflammatory cytokines in coronary heart disease patients.
Jiang Y; Du T
J Clin Lab Anal; 2022 Feb; 36(2):e24202. PubMed ID: 34997773
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease.
Wang W; Li Z; Zheng Y; Yan M; Cui Y; Jiang J
Lipids Health Dis; 2019 Jan; 18(1):22. PubMed ID: 30670045
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
